FDA Warns Pfizer Subsidiary Over Faulty EpiPen Components
By Michael Mezher -
Published 07 September 2017
The US Food and Drug Administration (FDA) on Tuesday warned Pfizer subsidiary Meridian Medical Technologies for failing to adequately investigate faulty components used to make EpiPen and EpiPen Jr auto-injectors for Mylan.
Categories: News, US, FDA, Combination products, Drugs
Tags: Meridian Medical Technologies, Pfizer, Mylan, EpiPen, Warning Letter